| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | Mar 13, 2025 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 48.8 | -2,153 | -1.09% | ✓ | $24.5K |
| Mar 5, 2025 | Mar 7, 2025 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 51.3 | -1,094 | -0.55% | ✓ | $12.9K |
| Feb 18, 2025 | Feb 25, 2025 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 48.8 | -2,598 | -1.29% | ✓ | $36.2K |
| Dec 11, 2024 | Dec 11, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -2,334 | -1.14% | ✓ | $65.6K |
| Nov 18, 2024 | Nov 18, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 41.3 | -2,856 | -2.03% | ✓ | $80.5K |
| Sep 18, 2024 | Sep 19, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -2,339 | -1.64% | ✓ | $80.8K |
| Sep 11, 2024 | Sep 11, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -2,161 | -1.49% | ✓ | $68.9K |
| Aug 19, 2024 | Aug 20, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -2,636 | -1.79% | ✓ | $118.9K |
| Jun 11, 2024 | Jun 11, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -2,136 | -1.43% | ✓ | $66.9K |
| May 20, 2024 | May 22, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 15.0 | -30,426 | -16.90% | ✓ | $1M |
| May 16, 2024 | May 17, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -2,705 | -1.78% | ✓ | $76.5K |
| Mar 11, 2024 | Mar 12, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -2,081 | -1.35% | ✓ | $53.5K |
| Mar 7, 2024 | Mar 11, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -2,373 | -1.51% | ✓ | $61.3K |
| Jan 3, 2024 | Jan 4, 2024 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 20.0 | -87,779 | -10.84% | ✓ | $1.6M |
| Dec 11, 2023 | Dec 12, 2023 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 51.3 | -1,467 | -0.82% | ✓ | $15.7K |
| Sep 18, 2023 | Sep 20, 2023 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 48.8 | -1,436 | -1.67% | ✓ | $13.5K |
| Sep 12, 2023 | Sep 13, 2023 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 48.8 | -1,484 | -1.70% | ✓ | $15.4K |
| Jun 13, 2023 | Jun 14, 2023 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 48.8 | -1,475 | -1.66% | ✓ | $18.3K |
| Mar 14, 2023 | Mar 15, 2023 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 48.8 | -1,416 | -1.57% | ✓ | $18.9K |
| Dec 9, 2022 | Dec 13, 2022 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 90.0 | +39,320 | 77.36% | ✓ | $7.4K |
| Sep 20, 2022 | Sep 21, 2022 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -1,413 | -2.70% | ✓ | $19.4K |
| Sep 15, 2022 | Sep 15, 2022 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 48.8 | -712 | -1.34% | ✓ | $10K |
| Jun 14, 2022 | Jun 15, 2022 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 50.0 | -726 | -1.35% | ✓ | $3.6K |
| Mar 11, 2022 | Mar 14, 2022 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 50.0 | -693 | -1.27% | ✓ | $6K |
| Sep 20, 2021 | Sep 22, 2021 | Dyne Therapeutics, Inc. | Chief Scientific Officer | Sell | 36.3 | -1,444 | -7.49% | ✓ | $23K |